Some Companies Say 'No' To China's Latest VBP Round

Branded Growth Without Price Cuts Still Possible

 
• By Brian Yang

Only three of 40 qualified international drug firms won in the latest round of China's central bidding process, showing a toughening environment. But some companies are seemingly determined not to lower prices any further.

Concept of agreement - a man carrying a briefcase walks through a large keyhole
MNCs MOSTLY SAY 'NO' TO LOWERING PRICES IN CHINA'S LATEST VPB ROUND • Source: Shutterstock

More from China

More from Focus On Asia